Loading

Editorial Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.46439/rheumatology.4.025

Exploring novel therapeutic avenues for arthritis precision medicine: The potential of mTOR-SIRT1, NRF2, GPX4 ferroptosis- and autophagy- related pathways and emerging technologies

  • 1Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, Guangdong, China
  • 2Xijing Hospital of Air Force Military Medical University, Xian, China
  • 3Hezhou (the City of Longevity) Dongrong Yao Medicine Research Institute, Joint Institute of Shenzhen University and Hezhou Hospital for Traditional Chinese Medicine, Hezhou, Guangxi, China
  • 4Department of Rheumatology and Immunology, The First Clinical College of Harbin Medical University, Harbin, Heilongjiang, China
  • 5Integrated Chinese and Western Medicine Research Institute, TORAMI Matrix Longevity and Healthcare hub, Zheng He Hospital, Changsha, Hunan, China
  • #Contributed equally
+ Affiliations - Affiliations

Corresponding Author

Yue Zhang, toronto101@163.com

Received Date: August 07, 2024

Accepted Date: October 03, 2024

Author Information X